West Pharmaceutical Services WST Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is West Pharmaceutical Services's net income?
- West Pharmaceutical Services (WST) reported net income of $138.8M in Q1 2026.
- How has West Pharmaceutical Services's net income changed year-over-year?
- West Pharmaceutical Services's net income increased by 54.6% year-over-year, from $89.8M to $138.8M.
- What is the long-term trend for West Pharmaceutical Services's net income?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's net income has grown at a -7.1% compound annual growth rate (CAGR), from $661.8M to $493.7M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.